Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda
The Oncologist · 2024
DOI: 10.1093/oncolo/oyad291 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Fidel Rubagumya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Rwanda Military Hospital, Kicukiro, Kigali, Rwanda. Hauptthemen laut MEDLINE: Breast Neoplasms, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Cancer is a major public health problem in Rwanda and other low- and middle-income countries (LMICs). While there have been some improvements in access to cancer treatment, the cost of care has increased, leading to financial toxicity and treatment barriers for many patients. This study explores the financial toxicity of cancer care in Rwanda.
Methods
This prospective cross-sectional study was conducted at 3 referral hospitals in Rwanda, which deliver most of the country’s cancer care. Data were collected over 6 months from June 1 to December 1, 2022 by trained research assistants (RAs) using a modified validated data collection tool. RAs interviewed consecutive eligible patients with breast cancer, cervical cancer, colorectal cancer, Hodgkin’s and non-Hodgkin’s lymphoma who were on active systemic therapy. The study aimed to identify sources of financial burden. Data were analyzed using descriptive statistics.
Results
239 patients were included; 75% (n = 180/239) were female and mean age was 51 years. Breast, cervix, and colorectal cancers were the most common diagnoses (42%, 100/239; 24%, 58/239; and 24%, 57/239, respectively) and 54% (n = 129/239) were diagnosed with advanced stage (stages III-IV). Financial burden was high; 44% (n = 106/239) of respondents sold property, 29% (n = 70/239) asked for charity from public, family, or friends, and 16% (n = 37/239) took loans with interest to fund cancer treatment.
Conclusion
Despite health insurance which covers many elements of cancer care, a substantial proportion of patients on anti-cancer treatment in Rwanda experience major financial toxicity. Novel health financing solutions are needed to ensure accessible and affordable cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Rwanda Military Hospital, Kicukiro, Kigali, Rwanda.
- Department of Oncology, Research for Development (RD), Gasabo, Kigali, Rwanda.
- Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.
- Departments of Oncology, Queen's University, Kingston, Ontario, Canada.
- Department of Oncology, Dartmouth Cancer Center, Lebanon, NH, USA.
- University of Sydney, School of Public Health, Sydney, NSW, Australia.
ORCID-Profile: Fidel Rubagumya
Zitieren
APA
Rubagumya, F., Wilson, B., Manirakiza, A., Mutabazi, E., A Ndoli, D., Rudakemwa, E., Chamberlin, M. D., Hopman, W. M., & Booth, C. M. (2024). Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda. The Oncologist. https://doi.org/10.1093/oncolo/oyad291
Vancouver
Rubagumya F, Wilson B, Manirakiza A, Mutabazi E, A Ndoli D, Rudakemwa E, et al. Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda. The Oncologist. 2024. doi:10.1093/oncolo/oyad291
BibTeX
@article{Rubagumya2024,
author = {Rubagumya, Fidel and Wilson, Brooke and Manirakiza, Achille and Mutabazi, Emmanuel and A Ndoli, Diane and Rudakemwa, Emmanuel and Chamberlin, Mary D and Hopman, Wilma M and Booth, Christopher M},
title = {Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyad291}
}
EUVIMED